Metraipolis › archive › dc_6645810ee34c
Risks of pelvic inflammatory disease and bacterial vaginosis in adenomyosis patients using levonorgestrel intrauterine device or oral norethindrone — Europe PMC PMID:41404506
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41404506
- DOI
- 10.3389/fendo.2025.1703310
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T02:40:35.517Z
- SHA-256 of the archived text
7b4a858c5f615ebe7fd5ac324a7085dbb959d81e5443c8783544bf52b1fd8087- Stable URL of this page
https://metraipolis.com/documento/dc_6645810ee34c
How to cite
Risks of pelvic inflammatory disease and bacterial vaginosis in adenomyosis patients using levonorgestrel intrauterine device or oral norethindrone — Europe PMC PMID:41404506 — Europe PMC (en), https://europepmc.org/article/MED/41404506 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6645810ee34c (Metraipolis archive dc_6645810ee34c, sha256 7b4a858c5f615ebe7fd5ac324a7085dbb959d81e5443c8783544bf52b1fd8087)
BibTeX
@misc{dc6645810ee34c,
title = {Risks of pelvic inflammatory disease and bacterial vaginosis in adenomyosis patients using levonorgestrel intrauterine device or oral norethindrone — Europe PMC PMID:41404506},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41404506},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6645810ee34c; sha256 7b4a858c5f615ebe7fd5ac324a7085dbb959d81e5443c8783544bf52b1fd8087},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41404506. Agents can read the archived copy with the MCP tool read_document.